Drug Type siRNA |
Synonyms RBD 9079, RBD9079 |
Target |
Action inhibitors |
Mechanism AGT inhibitors(Angiotensinogen inhibitors), PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | Preclinical | China | 01 Jan 2025 | |
| Hypertension | Preclinical | China | 24 Jul 2023 |





